Tim Gynmed klinike iznimno je angažiran u daljnjem poboljšanju zakonodavstva kojime se regulira ova problematika, kao i daljnjem poboljšanju postupaka pobačaja i brige o ženama. Naše nove spoznaje, koje slijede ova nastojanja, periodično obajvljujemo u medicinskim časopisima, na engleskom i njemačkom jeziku. U nastavku je popis radova.


  • Abortion: legislation and statistics in Europe

    The European Journal of Contraception & Reproductive Health Care, Christian Fiala, Aubert Agostini, Teresa Bombas, Roberto Lertxundi, Marek Lubusky, Mirella Parachini & Kristina Gemzell-Danielsson, 14.04.2022

  • Experiences of Women Accessing an Abortion Clinic Confronted by Religiously Motivated Demonstrators: A Pilot Study

    PubMed, Christian Fiala, Johanna Özogul, Jennifer Kernreiter, 21.04.2020

  • Management of Very Early Medical abortion - An International Survey Among Providers

    PubMed, Christian Fiala, Teresa Bombas, Mirella Parachini, Aubert Agostini, Roberto Lertxundi, Marek Lubusky, Laurence Saya, Kristina Gemzell Danielsson, 01.02.2020

  • Management of Pain Associated With up-to-9-weeks Medical Termination of Pregnancy (MToP) Using Mifepristone-Misoprostol Regimens: Expert Consensus Based on a Systematic Literature Review

    PubMed, C Fiala, A Agostini, T Bombas, S Cameron, R Lertxundi, M Lubusky, M Parachini, L Saya, B Trumbic, K Gemzell Danielsson, 03.09.2019

  • Outcome of first trimester medical termination of pregnancy: definitions and management

    Christian Fiala, Sharon Cameron, Teresa Bombas, Mirella Parachini, Aubert Agostini, Roberto Lertxundi, Marek Lubusky, Laurence Saya & Kristina Gemzell Danielsson, 02.01.2019

    Pdf, 2.02 MBLink
  • hCG Testing to Determine Outcome after Medical Abortion: A Review

    J Preg Child Health , Christian Fiala, Teresa Bombas, Mirella Parachini, Aubert Agostini, Roberto Lertxundi, Marek Lubusky and Kristina Gemzell Danielsson, 2019

    Pdf, 679.21 KBLink
  • Early Medical Abortion - A Practical Guide For Healthcare Professionals

    Editions de Santé, Dr Christian FIALA, Pr Aubert AGOSTINI, Dr Teresa-Alexandra CARMO-BOMBAS, Pr Kristina GEMZELL-DANIELSSON, Dr Roberto LERTXUNDI, Pr Marek LUBUSKY, Dr Mirella PARACHINI, 2018

    Pdf, 1.47 MB
  • Pain management for up to 9 weeks medical abortion - An international survey among abortion providers.

    Eur J Obstet Gynecol Reprod Biol. , Fiala C, Cameron S, Bombas T, Parachini M, Agostini A, Lertxundi R, Gemzell-Danielsson K., 2018

    Pdf, 92.23 KBLink
  • Efficacy and safety of very early medical termination of pregnancy: a cohort study.

    PubMed, Bizjak I, Fiala C, Berggren L, Hognert H, Sääv I, Bring J, Gemzell-Danielsson K, 27.09.2017

  • There is no defense for ‘Conscientious objection’ in reproductive health care

    Christian Fiala, Joyce H. Arthur, July 2017

    Pdf, 510.53 KBLink
  • Assessment of pain during medical abortion with home use of misoprostol.

    PubMed, Cavet S, Fiala C, Scemama A, Partouche H, 22.06.2017

  • The dishonourable disobedience of not providing abortion.

    PubMed, Arthur J, Fiala C, Gemzell Danielsson K, Heikinheimo O, Guðmundsson JA, 22.02.2017

  • Routine misoprostol before all surgical abortions.

    PubMed, Cameron S, Fiala C, Gemzell-Danielsson K, November 2016

  • Yes we can! Successful examples of disallowing 'conscientious objection' in reproductive health care.

    Fiala C, Gemzell Danielsson K, Heikinheimo O, Guðmundsson JA, Arthur J., 03.02.2016

    Pdf, 750.07 KB
  • Medical Abortion beyond the 1st trimester

    Editions de Santé, Kristina GEMZELL-DANIELSSON, Christian FIALA,
 Sharon CAMERON, Teresa BOMBAS, Roberto LERTXUNDI, Marek LUBUSKY, Mirella PARACHINI, 2016

    Pdf, 6.68 MB
  • Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial.

    PubMed, Oppegaard KS, Qvigstad E, Fiala C, Heikinheimo O, Benson L, Gemzell-Danielsson K, 21.02.2015

  • Sublingual versus vaginal misoprostol for cervical dilatation 1 or 3 h prior to surgical abortion: a double-blinded RCT 

    Human Reproduction, Ingrid Saav; Helena Kopp Kallner; Christian Fiala; Kristina Gemzell-Danielsson, 2015

  • Instability of misoprostol tablets stored outside the blister: a potential serious concern for clinical outcome in medical abortion.

    PubMed, Berard V, Fiala C, Cameron S, Bombas T, Parachini M, Gemzell-Danielsson K, 15.12.2014

  • Pain during medical abortion, the impact of the regimen: a neglected issue? A review.

    PubMed, Fiala C, Cameron S, Bombas T, Parachini M, Saya L, Gemzell-Danielsson K., December 2014

  • Why We Need to Ban ‘Conscientious Objection’ in Reproductive Health Care

    Joyce Arthur, Abortion Rights Coalition of Canada and Christian Fiala, Gynmed Clinic for Abortion and Family Planning, 14.05.2014

  • “Dishonourable disobedience” – Why refusal to treat in reproductive healthcare is not conscientious objection

    Christian Fiala, Joyce H. Arthur, March 2014

  • Conscientious objection and induced abortion in Europe.

    Eur J Contracept Reprod Health Care, Heino A, Gissler M, Apter D, Fiala C., August 2013

  • Is the introduction of anonymous delivery associated with a reduction of high neonaticide rates in Austria?

    BJOG, Klier CM, Grylli C, Amon S, Fiala C, Weizmann-Henelius G, Pruitt SL, Putkonen H., 05.12.2012

  • Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion

    Contraception, Kopp Kallner H, Fiala C, Gemzell-Danielsson K., 85(4):394-7., April 2012

  • Effect of bacterial vaginosis on the pharmacokinetics of misoprostol in early pregnancy.

    Hum Reprod., Sioutas A, Sandström A, Fiala C, Watzer B, Schweer H, Gemzell-Danielsson K., February 2012

  • Medical abortion in lactating women - low levels of mifepristone in breast milk

    Acta Obstet Gynecol Scand., Sääv I, Fiala C,Hämäläinen JM, Heikinheimo O, Gemzell-Danielsson K., 89(5):618-22, May 2010

  • Home self administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days

    Hum Reprod., Kopp Kallner H, Fiala C, Stephansson O, Gemzell-Danielsson K., 25(5):1153-7, May 2010

  • Providing Medical Abortion in Low-Resource Settings

    Gynuity, 2009

    Pdf, 88.55 KB
  • Evaluation of Early Medical Abortion (EMA) Pilot Sites

    University of Southampton and Department of Health, London , Roger Ingham and Ellie Lee et al., 07.05.2008

  • Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy

    Int J Gynaecol Obstet., Faundes A, Fiala C, Tang OS, Velasco A., 99 Suppl 2:S172-7, December 2007

  • Misoprostol for intrauterine fetal death

    Int J Gynaecol Obstet., Gómez Ponce de León R, Wing D, Fiala C, 99 Suppl 2:S190-3, December 2007

  • Cervical priming with misoprostol prior to transcervical procedures

    Int J Gynaecol Obstet., Fiala C, Gemzell-Danielsson K., Tang OS, von Hertzen H, 99 Suppl 2:S168-71, December 2007

  • Misoprostol: first-line therapy for incomplete miscarriage in the developing world

    BJOG, Gemzell-Danielsson K, Fiala C, Weeks A., 114(11):1337-9, November 2007

  • Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol

    Hum Reprod., Aronsson A, Fiala C, Stephansson O, Granath F, Watzer B, Schweer H, Gemzell-Danielsson K., 22(7):1912-8, July 2007

  • Restricting access to safe abortion poses a serious health risk for women

    ESC newsletter, ESC, European Society of Contraception: Expert Group on abortion - C. Fiala, Austria and C. Gemzell, Sweden, June 2007

    Pdf, 438.62 KB
  • Review of medical abortion using mifepristone in combination with a prostaglandin analogue

    Contraception, Fiala C, Gemzel-Danielsson K., 74(1):66-86, July 2006

  • Frequently asked clinical questions about medical abortion

    WHO, 2006

    Pdf, 200 KBLink
  • Pharmacokinetics of a novel oral slow-release form of misoprostol

    Hum Reproduction, Fiala C, Aronsson A, Granath F, Stephansson O, Seyberth HW, Watzer B, Gemzell-Danielsson K., 20(12):3414-8, December 2005

  • The effect of non-steroidal anti-inflammatory drugs (NSAIDs) on medical abortion with mifepristone and misoprostol at 13 to 22 weeks gestation

    Human Reproduction, C. Fiala, ML. Swahn, O. Stephansson, and K. Gemzell-Danielsson, 20(11):3072-7, November 2005

  • Effects of slow release misoprostol on uterine contractility in early pregnancy

    Human Reproduction, C. Fiala, A. Aronsson, O. Stephansson and K. Gemzell-Danielsson, 20(9):2648-52., September 2005

  • Abortion in Europe: Are the Laws and Practices patient centered?

    Entre Nous magazine, UNFPA/ WHO No. 59, Christian Fiala, 23/5, 2005

    Pdf, 28.86 KB
  • Acceptability of home-use of misoprostol in medical abortion

    Contraception, Fiala C, Winikoff B, Helstrom L, Hellborg M, Gemzell-Danielsson K., 70(5):387-92., November 2004

  • Rh-prophylaxis in early abortion

    Acta Obstet Gynecol Scand., Fiala C, Fux M, Gemzell Danielsson K., 82(10):892-903. Review, October 2003

  • Verifying the effectiveness of medical abortion; ultrasound versus hCG testing

    Eur J Obstet Gynecol Reprod Biology, Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K., 109(2):190-5., 15.08.2003

  • Medical abortion - where we are in Europe

    Entre Nous magazine, UNFPA/ WHO No 47-48, Christian Fiala, 16-17, September 2000